Table 3 Advantages and disadvantages of different novel vaccines
Novel vaccines | security of production | security of vaccinated animal | shelf life | duration of immune response | vaccination effectiveness | Differentiation of infected animals from vaccinated ones |
|---|---|---|---|---|---|---|
Subunit vaccine | Yes | Yes | Normal | Normal | Low | Yes |
Live vector vaccine | Yes | Yes | Normal | Long | High | Yes |
Nucleic acid vaccine | Yes | Risk to recombinant to other genomes | Long | Long | Low | Yes |
Novel attenuated vaccine | Yes | Risk to toxicity reversion but low | Normal | Long | High | Yes |
Synthetic peptide vaccine | Yes | Yes | Normal | Short | Low | Yes |